Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
26.79
+2.51 (10.34%)
At close: Oct 29, 2025, 4:00 PM EDT
27.50
+0.71 (2.65%)
After-hours: Oct 29, 2025, 7:54 PM EDT

Beta Bionics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22
Net Income
-77.84-54.76-44.1-64.75
Depreciation & Amortization
2.472.282.092.09
Other Amortization
---0.01
Loss (Gain) From Sale of Assets
0.020.020.010.04
Loss (Gain) From Sale of Investments
-2.65-2.91-0.75-
Stock-Based Compensation
13.636.385.666.1
Provision & Write-off of Bad Debts
0.050.070.05-
Other Operating Activities
18.2812.789.9-0.91
Change in Accounts Receivable
-4.13-7.62-4.49-
Change in Inventory
-8.89-11.44-1.19-
Change in Accounts Payable
1.511.520.72-0.08
Change in Unearned Revenue
2.312.460.34-0.18
Change in Other Net Operating Assets
-1.342.94-0.68-2.53
Operating Cash Flow
-56.58-48.27-32.45-60.21
Capital Expenditures
-3.96-3.4-0.4-0.77
Sale of Property, Plant & Equipment
-0.0500
Investment in Securities
-189.17-0.13-69.3-
Investing Cash Flow
-193.13-3.48-69.69-0.77
Issuance of Common Stock
213.850.10.030.39
Other Financing Activities
-2.81-4.15-11.41
Financing Cash Flow
270.7155.62101.0356.78
Net Cash Flow
213.87-1.11-4.2
Free Cash Flow
-60.53-51.67-32.85-60.98
Free Cash Flow Margin
-68.34%-79.34%-273.84%-34067.04%
Free Cash Flow Per Share
-1.94-8.12-6.19-12.20
Levered Free Cash Flow
-43.43-35.24-19.66-
Unlevered Free Cash Flow
-43.43-35.24-19.66-
Change in Working Capital
-10.53-12.15-5.31-2.79
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q